news
API markets to grow 6.8 percent by 2026
Global active pharmaceutical ingredients market set to surpass US$274.9 billion by 2026.
List view / Grid view
Drug Markets
news
British Columbia first province to switch patients to biosimilars
British Columbia has said it will switch as many as 20,400 patients from three branded biologic drugs to cheap biosimilars.
news
CPhI China opens with analysis pointing to a surge in growth in 2019
Regulatory reforms and harmonisation reported as key drivers of industry in China.
news
Retail prices on several anti-cancer medications slashed
The retail prices of some anti-cancer drugs have been cut by 87 percent by the drug price control authority in India.
news
GSK and Novartis ‘misled’ consumers, says Federal Court of Australia
GSK and Novartis found to have misled consumers with the packaging and pricing of their osteoarthritis pain treatment.
news
Market for single-use bioprocessing systems in Asia Pacific rises
The single-use bioprocessing systems market in Asia Pacific has witnessed an impressive rise and is expected to continue growing.
news
US drugmakers allegedly collude on generic price hikes
A coalition of 43 attorneys general allege generic drug manufacturers colluded, overcharging US states and consumers billions.
news
Report shows US brand-name drug prices ‘highest in the world’
A new study has found that prices for brand-name prescription drugs averaged 3.2 to 4.1 times higher in the US compared with other countries.
news
Long-lasting opioid treatment recommended by an EMA committee
Marketing authorisation has been recommended in the EU by an EMA committee for Sixmo (buprenorphine) as a substitution treatment for opioid dependence.
news
Pharmaceutical company and its former executives charged for drug trafficking
The US government has filed criminal charges against Rochester Drug Co-Operative (RDC), one of the largest pharmaceutical distribution companies in the US, and its former CEO Laurence Doud III and former Chief of Compliance Officer, William Pietruszewski.
article
Is the pharma sector ready for a ‘no-deal’ Brexit?
With the UK bracing itself for a 'no-deal' Brexit or some other outcome that has not yet been determined, pharma experts discussed the potential effect of Brexit on the supply chain and how to best prepare for it against the upcoming deadline.
news
Drug prices come under fire as US pharma lobby nears spending records
More ambitious changes may be needed to lower pharmaceutical prices as the Trump administration proposes new rules and approves a slew of new generic drugs.
news
Big pharma blamed for skyrocketing US drug prices
Executives blamed high drug prices on the drugmakers and their pursuit of profits...
news
Heart drugs free from carcinogens identified as recalls drag on
The Food and Drug Administration has released a list of 40 drugs used to treat hypertension and heart failure that don’t contain any known carcinogens...
news
Needle-free ‘dominates’ injectable drug delivery market
Disposable injectors are the most commonly available type of injectors since they are user friendly and do not require special skills for administration...
